Login
Login

Category: Regulatory/FDA

FDA-News (1)

Bad Ad Complaints Yield Two OPDP Warning Letters, One on COVID Email Claims

Learn More
NewsRadio

Addyi Radio Ad Garners OPDP Warning Letter for Omission of Risks

Learn More
FDA-News (1)

Despite COVID-19 Distractions, FDA Approving Drugs at Fast Pace

Learn More
Dr. Stephen Hahn (1)

Hahn: Lessons Learned in Pandemic May Lead to Permanent FDA Changes

Learn More
FDA-News (1)

By One Measure, 2020 OPDP Enforcement Is Off to Slow Start

Learn More
thermometer-temperature-fever-flu

As COVID-19 Pandemic Continues, Promotion of Unapproved “Cures” Abounds

Learn More
FDA-News (1)

COVID-19 Pandemic Likely to Affect FDA Product Approval Timelines

Learn More
CHC_FDA-Regulatory Images1

FDA Streamlines COVID-19 Product Pathways, Continues to Crack Down on Misleading Claims

Learn More
CHC_FDA-Regulatory Images1

FDA and FTC: Coronavirus Products Are Fraudulent, Could Delay Treatment

Learn More